Latest Regulatory News

Inoviq Ltd's trading suspension has been lifted following new disclosures, but the ASX continues to investigate the company's compliance with listing rules.

INOVIQ Limited has revealed promising data for its EXO-OC™ ovarian cancer screening test, demonstrating exceptional accuracy and flawless detection of early-stage cancers. This innovation could transform early diagnosis and treatment outcomes for women worldwide.

Loyal Lithium Limited remains suspended from ASX trading after missing its deadline to disclose details of a proposed acquisition and respond to a price query, raising fresh questions about the company’s compliance and strategic direction.

James Hardie Industries is set to terminate its American Depositary Share program following its merger with The AZEK Company and direct NYSE listing, simplifying its share structure for investors.

James Hardie Industries has successfully syndicated $3.5 billion in new credit facilities, providing robust financial backing for its planned merger with The AZEK Company Inc. This move significantly reduces prior bridge loan commitments and enhances the company’s financial flexibility.

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Vinyl Group Ltd has voluntarily suspended trading on the ASX pending a Federal Court decision on its application for relief after failing to lodge required cleansing notices on time.

Bio-Gene Technology Limited has raised $338,500 through a Share Purchase Plan, contributing to a total capital raise of $2.45 million to advance its bio-insecticide products.

Neurotech International has reported positive human pharmacokinetic results for NTI164, a cannabinoid formulation designed for paediatric neurological disorders, confirming rapid absorption and a non-intoxicating profile.

EV Resources Limited has agreed to sell its Yanamina Gold and Silver Project in Peru to Daura Gold Corp for US$6 million, a move that will bolster EVR’s cash reserves and sharpen its strategic focus.

Redivium Limited has secured a definitive five-year marketing and offtake agreement with WMC Energy BV, ensuring exclusive global sales of black mass from its UK battery recycling facility.

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.